Derek M. Meisner, General Counsel at X4 Pharmaceuticals, Inc (XFOR), sold 8,332 shares at $5.10 ($42K) on 2021-08-17, disclosed to the SEC on 2021-08-19.
Scheduled sale ($42k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ABOS | SELL | 2026-01-28 | $107K | — | Filing → |
| ABOS | SELL | 2026-01-23 | $31K | — | Filing → |
| ABOS | SELL | 2026-01-12 | $182K | — | Filing → |